Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 824746, 14 pages
http://dx.doi.org/10.1155/2015/824746
Research Article

Encapsulation of Curcumin in Diblock Copolymer Micelles for Cancer Therapy

1Cancer Research Center, Tehran University of Medical Sciences, Tehran 14197-33141, Iran
2Department of Genetics, School of Biological Sciences, Tarbiat Modares University, Tehran 14115-137, Iran
3Department of Resin and Additives, Institute for Color Science and Technology, Tehran 16765-654, Iran
4Immunology Lab, Institute of Biochemistry and Biophysics, University of Tehran, Tehran 13145-1384, Iran
5Department of Biotechnology, Faculty of Advanced Medical Technology, Golestan University of Medical Sciences, Gorgan 49175-553, Iran
6Department of Pathology, School of Medicine, Tehran University of Medical Sciences, Tehran 14197-33141, Iran
7School of Biological Science, Damghan University, Damghan 36716-41167, Iran
8Cancer Model Research Center, Tehran University of Medical Sciences, Tehran 14197-33141, Iran

Received 9 June 2014; Revised 22 October 2014; Accepted 23 October 2014

Academic Editor: Bruno C. Cavalcanti

Copyright © 2015 Ali Mohammad Alizadeh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Bayet-Robert and D. Morvan, “Metabolomics reveals metabolic targets and biphasic responses in breast cancer cells treated by curcumin alone and in association with docetaxel,” PLoS ONE, vol. 8, no. 3, Article ID e57971, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Anand, A. B. Kunnumakkara, R. A. Newman, and B. B. Aggarwal, “Bioavailability of curcumin: problems and promises,” Molecular Pharmaceutics, vol. 4, no. 6, pp. 807–818, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Kakarala, D. E. Brenner, H. Korkaya et al., “Targeting breast stem cells with the cancer preventive compounds curcumin and piperine,” Breast Cancer Research and Treatment, vol. 122, no. 3, pp. 777–785, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. S. Dhule, P. Penfornis, T. Frazier et al., “Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 8, no. 4, pp. 440–451, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Ghalandarlaki, A. M. Alizadeh, and S. Ashkani-Esfahani, “Nanotechnology-applied curcumin for different diseases therapy,” BioMed Research International, vol. 2014, Article ID 394264, 23 pages, 2014. View at Publisher · View at Google Scholar
  6. T. G. Shutava, S. S. Balkundi, P. Vangala et al., “Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols,” ACS Nano, vol. 3, no. 7, pp. 1877–1885, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Le Droumaguet, J. Nicolas, D. Brambilla et al., “Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and alzheimer's disease,” ACS Nano, vol. 6, no. 7, pp. 5866–5879, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. F. D. Ledley, “Nonviral gene therapy: the promise of genes as pharmaceutical products,” Human Gene Therapy, vol. 6, no. 9, pp. 1129–1144, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Suwannateep, S. Wanichwecharungruang, S. F. Haag et al., “Encapsulated curcumin results in prolonged curcumin activity in vitro and radical scavenging activity ex vivo on skin after UVB-irradiation,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 82, no. 3, pp. 485–490, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Babaei, M. Sadeghizadeh, Z. M. Hassan, M. A. H. Feizi, F. Najafi, and S. M. Hashemi, “Dendrosomal curcumin significantly suppresses cancer cell proliferation in vitro and in vivo,” International Immunopharmacology, vol. 12, no. 1, pp. 226–234, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Khaniki, S. Azizian, A. M. Alizadeh, H. Hemmati, N. Emamipour, and M. A. Mohagheghi, “The antiproliferative and anticancerogenic effects of nano-curcumin in rat colon cancer,” Tehran University Medical Journal, vol. 71, no. 5, pp. 277–284, 2013. View at Google Scholar · View at Scopus
  12. M. N. Sarbolouki, A. M. Alizadeh, M. Khaniki, S. Azizian, and M. A. Mohaghgheg, “Protective effect of dendrosomal curcumin combination on colon cancer in rat,” Tehran University Medical Journal, vol. 69, no. 11, pp. 678–685, 2012. View at Google Scholar · View at Scopus
  13. M. T. Mirgani, B. Isacchi, M. Sadeghizadeh et al., “Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells,” International Journal of Nanomedicine, vol. 9, no. 1, pp. 403–417, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Sahu, U. Bora, N. Kasoju, and P. Goswami, “Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells,” Acta Biomaterialia, vol. 4, no. 6, pp. 1752–1761, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Bisht, G. Feldmann, S. Soni, R. Ravi, C. Karikar, and A. Maitra, “Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy,” Journal of Nanobiotechnology, vol. 5, article 3, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. Ma, A. Haddadi, O. Molavi, A. Lavasanifar, R. Lai, and J. Samuel, “Micelles of poly(ethylene oxide)-b-poly(ε-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin,” Journal of Biomedical Materials Research Part A, vol. 86, no. 2, pp. 300–310, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Gou, K. Men, H. Shi et al., “Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo,” Nanoscale, vol. 3, no. 4, pp. 1558–1567, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Song, Y. Shen, J. Hou, L. Lei, S. Guo, and C. Qian, “Polymeric micelles for parenteral delivery of curcumin: preparation, characterization and in vitro evaluation,” Colloids and Surfaces A: Physicochemical and Engineering Aspects, vol. 390, no. 1–3, pp. 25–32, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55–63, 1983. View at Publisher · View at Google Scholar · View at Scopus
  20. R. A. Sharma, A. J. Gescher, and W. P. Steward, “Curcumin: the story so far,” European Journal of Cancer, vol. 41, no. 13, pp. 1955–1968, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Mohsenikia, A. M. Alizadeh, S. Khodayari et al., “The protective and therapeutic effects of alpha-solanine on mice breast cancer,” European Journal of Pharmacology, vol. 718, no. 1-3, pp. 1–9, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. A. M. Alizadeh, M. Faghihi, V. Khori et al., “Oxytocin protects cardiomyocytes from apoptosis induced by ischemia-reperfusion in rat heart: role of mitochondrial ATP-dependent potassium channel and permeability transition pore,” Peptides, vol. 36, no. 1, pp. 71–77, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-L. Achard, I. van Praagh, and V. Feillel, “Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy,” International Journal of Oncology, vol. 20, no. 4, pp. 791–796, 2002. View at Google Scholar · View at Scopus
  24. A. M. Alizadeh, M. Khaniki, S. Azizian, M. A. Mohaghgheghi, M. Sadeghizadeh, and F. Najafi, “Chemoprevention of azoxymethane-initiated colon cancer in rat by using a novel polymeric nanocarrier-curcumin,” European Journal of Pharmacology, vol. 689, no. 1–3, pp. 226–232, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Vila, A. Sánchez, M. Tobío, P. Calvo, and M. J. Alonso, “Design of biodegradable particles for protein delivery,” Journal of Controlled Release, vol. 78, no. 1–3, pp. 15–24, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. R. H. Müller, C. Jacobs, and O. Kayser, “Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future,” Advanced Drug Delivery Reviews, vol. 47, no. 1, pp. 3–19, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Ravindran, S. Prasad, and B. B. Aggarwal, “Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?” AAPS Journal, vol. 11, no. 3, pp. 495–510, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. Y.-J. Wang, M.-H. Pan, A.-L. Cheng et al., “Stability of curcumin in buffer solutions and characterization of its degradation products,” Journal of Pharmaceutical and Biomedical Analysis, vol. 15, no. 12, pp. 1867–1876, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Heyes, K. Hall, V. Tailor, R. Lenz, and I. MacLachlan, “Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery,” Journal of Controlled Release, vol. 112, no. 2, pp. 280–290, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Wei, C. Gong, M. Gou et al., “Biodegradable poly(ε-caprolactone)-poly(ethylene glycol) copolymers as drug delivery system,” International Journal of Pharmaceutics, vol. 381, no. 1, pp. 1–18, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Maeda, Y.-S. Chung, S. Takatsuka et al., “Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma,” British Journal of Cancer, vol. 72, no. 2, pp. 319–323, 1995. View at Publisher · View at Google Scholar · View at Scopus
  32. J.-M. Zingg, S. T. Hasan, and M. Meydani, “Molecular mechanisms of hypolipidemic effects of curcumin,” BioFactors, vol. 39, no. 1, pp. 101–121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. E. C. M. Mommers, P. J. van Diest, A. M. Leonhart, C. J. L. M. Meijer, and J. P. A. Baak, “Balance of cell proliferation and apoptosis in breast carcinogenesis,” Breast Cancer Research and Treatment, vol. 58, no. 2, pp. 163–169, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. J. B. Baell and D. C. S. Huang, “Prospects for targeting the Bcl-2 family of proteins to develop novel cytotoxic drugs,” Biochemical Pharmacology, vol. 64, no. 5-6, pp. 851–863, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Karunagaran, R. Rashmi, and T. R. Santhosh Kumar, “Induction of apoptosis by curcumin and its implications for cancer therapy,” Current Cancer Drug Targets, vol. 5, no. 2, pp. 117–129, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. R. J. Anto, A. Mukhopadhyay, K. Denning, and B. B. Aggarwal, “Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl,” Carcinogenesis, vol. 23, no. 1, pp. 143–150, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Folkman, “What is the evidence that tumors are angiogenesis dependent?” Journal of the National Cancer Institute, vol. 82, no. 1, pp. 4–6, 1990. View at Publisher · View at Google Scholar · View at Scopus
  38. S. B. Fox, D. G. Generali, and A. L. Harris, “Breast tumour angiogenesis,” Breast Cancer Research, vol. 9, no. 6, article 216, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Anand, H. B. Nair, B. Sung et al., “Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo,” Biochemical Pharmacology, vol. 79, no. 3, pp. 330–338, 2010. View at Publisher · View at Google Scholar · View at Scopus